Motor neuron death in amyotrophic lateral sclerosis may stem from a vicious cycle where cellular stress overwhelms the brain's ability to regulate glutamate, the primary excitatory neurotransmitter. This dysregulation creates a cascade of damage that accelerates disease progression through what researchers term excitotoxicity.
The pathological process involves multiple converging factors that disrupt glutamate homeostasis in motor neurons. Mutations in genes like SOD1, C9ORF72, TARDBP, and FUS trigger protein misfolding and aggregation, which impairs cellular machinery responsible for glutamate regulation. Under oxidative stress conditions, motor neurons lose their capacity to control calcium influx while mitochondrial and endoplasmic reticulum function deteriorates. This cellular dysfunction prevents proper glutamate clearance, allowing the neurotransmitter to accumulate to toxic levels. Simultaneously, astrocytes—the brain's support cells—become stressed and further reduce their glutamate uptake capacity, compounding the problem.
This mechanistic understanding represents a significant shift from viewing ALS as primarily a motor neuron disease to recognizing it as a complex network disorder involving neuron-glia interactions. The excitotoxicity framework helps explain why ALS symptoms often spread from initial focal areas to adjacent regions, as glutamate toxicity can propagate through neural circuits. For therapeutic development, this suggests that targeting glutamate regulation, calcium handling, or astrocyte function could potentially slow disease progression. However, the multifactorial nature of ALS means that effective treatments will likely require combination approaches rather than single-target interventions, making this a challenging but promising avenue for future research.